NEW YORK (GenomeWeb News) – Pacific Biosciences saw its second-quarter revenues fall 31 percent year over year, the company reported after the close of the market on Thursday, but the firm beat consensus Wall Street estimates on the top line and the bottom line.

For the three months ended June 30, PacBio took in $7.3 million in revenues, down from $10.6 million a year ago. Revenues beat analysts projections, however, which averaged $6.9 million for the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.